Skip to main content

Table 3 Comparison between the control group and different cytogenetic risk groups regarding BECN1 gene expression

From: Reductive regulation of BECN1 gene in adult Egyptian patients with do novo AML

  Control group Cytogenetic risk group P value Sig.
Favourable Intermediate Adverse
BECN1
Median (IQR)
1.12 (0.93–1.26) 1.04 (1.03–1.07) 0.44 (0.29–0.58) 0.34 (0.27–0.51) 0.000 HS
Post hoc analysis
  Control vs favourable Control vs intermediate Control vs adverse Favourable vs intermediate Favourable vs adverse Intermediate vs adverse
BECN1 0.052 0.000 0.000 0.008 0.000 0.469
  1. P value > 0.05: non-significant; P value < 0.05: significant; P value < 0.01: highly significant